A commercial stage 
pharmaceutical company, 
developing drugs 
through cutting-edge 
drug delivery technologies

Who we are

Orexo Insights: Read the interview here

Press releases & news

All press releases

AmorphOX®

- our proprietary drug delivery technology that improves bioavailability and stability for both large and small molecules

Discover AmorphOX

OX640: A revolutionary nasal epinephrine solution for anaphylaxis rescue

Find out more

Together we are stronger. Team up with us for product development and commercialization. 

For contact details

Orexo’s AmorphOX® Unlocks New Possibilities for Critical Medicines

Orexo Insights: Inverview with Robert Rönn, SVP & Head of R&D

Latest report

Report archive

 

Our partners

Orexo is committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, environment and anti-corruption. Read more on www.unglobalcompact.org.